class="wp-theme-Newspaper supp-body td-standard-pack global-block-template-1 tdc-header-template tdc-footer-template td-animation-stack-type0 td-full-layout"
Omega-3 supplementation pathway: anticoagulant effect. See omega-3 fatty acids. Direct eicosanoid supplements: minimal consumer data.
Fatty acid-derived bioactive lipid mediators. Omega-3/omega-6 dietary balance influences eicosanoid profiles. Direct eicosanoid supplementation limited to prostaglandin derivatives (pharmaceutical). Dietary manipulation via PUFA supplementation more common.
Acts on cellular signalling pathways relevant to the documented clinical indications. Contains bioactive compounds with enzyme-modulating, receptor-binding, or antioxidant properties studied in peer-reviewed literature.
| Population | Safety rating | Max safe dose |
|---|---|---|
| General | Possibly safe | — |
| Pregnancy | Possibly safe | — |
| Elderly | Possibly safe | — |
No peer-reviewed clinical trial data found for this ingredient.
Data by supplement.ge — Public Health Institute of Georgia (PHIG)